AI & RoboticsNews

McKinsey: Gen AI adoption rockets, generates value for enterprises

Organizations are in a wild race to adopt generative AI — it is one of the most significant technological innovations in a generation (or multiple generations).  In fact, just a year-and-a-half after ChatGPT was announced — changing the world as we know it — 65% of organizations are regularly using AI, according to a new report from consulting firm McKinsey. This is nearly double the…
Read more
AI & RoboticsNews

PwC strikes OpenAI deal to become the first reseller of ChatGPT Enterprise

Companies no longer need to buy a ChatGPT Enterprise license directly from OpenAI. They can now purchase the gen AI service through the multinational professional service consultancy PwC. Until today, businesses could only subscribe to the enterprise option by reaching out to an OpenAI salesperson. Now, there’s another way, but it also allows PwC to upsell its services to those who want to use…
Read more
AI & RoboticsNews

OpenAI is devouring the media industry

Let’s make one thing clear up front: I’m generally pro-generative AI. At least, I am a lot more amenable to it — and use it myself daily in the form of parsing information via ChatGPT and generating images with it and Midjourney — than many of my peers in the…
AI & RoboticsNews

Elon Musk’s xAI raises $6B to take on OpenAI

Today, Elon Musk’s xAI startup announced a massive $6 billion round of funding. Confirming reports from April, the series B investment comes from the participation of multiple known venture capital firms and investors, including Valor Equity Partners, Vy Capital, Andreessen Horowitz (A16z), Sequoia Capital, Fidelity Management & Research Company, Prince Alwaleed Bin Talal and Kingdom…
Read more
AI & RoboticsNews

McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI

Atropos Health, a healthcare technology company focused on generating personalized real-world evidence, announced today that it has raised $33 million in a Series B funding round. The round included strategic investments from healthcare giants McKesson, Merck, and Cencora Ventures, signaling strong industry interest in Atropos’ mission to bring automated, high-quality evidence to patient care…
Read more